ODR4: A Potential Drug Target and Biomarker for Various Diseases

Target Name: ODR4

NCBI ID: G54953

ODR4

ODR4: A Potential Drug Target and Biomarker for Various Diseases

ODR4 (Odor-4 gene product homolog) is a gene that encodes a protein known as GPCR localization factor homolog. This protein plays a crucial role in the development and progression of various diseases, including cancer. As a result, ODR4 has been identified as a potential drug target and biomarker for a variety of diseases.

ODR4 is a member of the G protein-coupled receptor (GPCR) family, which is a large superfamily of transmembrane proteins that play a central role in cellular signaling. GPCR proteins are involved in a wide range of physiological processes, including sensory perception, neurotransmission, and hormone signaling.

The ODR4 gene was first identified in 2007 and has since been widely studied. It is located on chromosome 18 and has been shown to encode a protein with multiple functional domains, including a transmembrane domain, a cytoplasmic domain, and an N-terminus that is involved in protein-protein interactions.

One of the most significant features of ODR4 is its ability to localize to specific protein-protein interaction sites within cells. This is achieved through its ability to interact with other proteins via its cytoplasmic domain, which is known as the C-terminal region. The C-terminal region is composed of multiple conserved amino acid residues that are involved in protein-protein interactions and are thought to play a key role in ODR4's localization and function.

ODR4 has also been shown to play a role in the regulation of cellular signaling pathways. For example, studies have shown that ODR4 can interact with the protein Pyknot, which is involved in the regulation of cell growth and differentiation. This interaction between ODR4 and Pyknot has been shown to play a role in the regulation of cell proliferation and the development of cancer.

In addition to its role in cellular signaling, ODR4 has also been shown to be involved in the regulation of gene expression. For example, studies have shown that ODR4 can interact with the protein p53, which is a well-known regulator of DNA damage repair. This interaction between ODR4 and p53 has been shown to play a role in the regulation of cellular responses to environmental stress, including stress caused by drugs.

As a result of its involvement in cellular signaling and gene regulation, ODR4 has been identified as a potential drug target and biomarker for a variety of diseases. For example, studies have shown that ODR4 is highly expressed in various types of cancer, including breast, ovarian, and prostate cancer. This suggests that targeting ODR4 with drugs or other therapeutic agents may be an effective way to treat these cancers.

In addition to its potential as a drug target, ODR4 has also been shown to be a potential biomarker for a variety of diseases. For example, studies have shown that ODR4 is expressed in various types of cancer, including breast, ovarian, and prostate cancer. This suggests that measuring ODR4 levels in cancer cells or tissues may be an effective way to diagnose or monitor the effectiveness of cancer treatments.

In conclusion, ODR4 is a gene that encodes a protein with multiple functional domains that is involved in cellular signaling and gene regulation. Its ability to localize to specific protein-protein interaction sites and its involvement in the regulation of cellular signaling pathways make it a potential drug target and biomarker for a variety of diseases. Further research is needed to fully understand the role of ODR4 in disease progression and the development of new therapeutic approaches.

Protein Name: Odr-4 GPCR Localization Factor Homolog

Functions: May play a role in the trafficking of a subset of G-protein coupled receptors

The "ODR4 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ODR4 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets